Regarding the evaluation of the daily symptoms, based on Table S1 , including weight-related scoring, the infected Ca37 mAb-treated group exhibited better overall well-being ( Figure 4 B), with a nearly significant difference in total symptom scores compared with the infected untreated group.
← all excerpts
Evaluation of the Ca37 Monoclonal Antibody Targeting Alcohol Dehydrogenase Against <i>Candidozyma auris</i> (<i>Candida auris</i>) In Vitro and In Vivo.
1
—
—